Magnetic resonance imaging as an outcome measure in the treatment of multiple sclerosis: results of the interferon beta trial

Abstract

Keywords

burden of disease lesion activity magnetic resonance imaging

Get full access to this article

View all access options for this article.

References

Kastrukoff

. (1990) Systemic lymphoblastoid interferon therapy in chronic progressive multiple sclerosis. I. Clinical and MRI evaluation. Neurology 40: 479-486.

Koopmans

, Li

DKB

, Zhao

, Redekop

, Paty

. MRI assessment of cyclosporine therapy of MS in a multicenter trial, (manuscript in preparation).

Stewart

, Hall

, Berry

, Paty

. (1984) Correlation between NMR scan and brain slice: data in multiple sclerosis. Lancet ii: 412.

Katz

. (1993) Gadolinium-enhancing lesions on magnetic resonance imaging. Neuropathological findings. Ann Neurol 34: 661-669.

Wolinsky

, Narayana

, Fenstermacher

. (1990) Proton magnetic resonance spectroscopy in multiple sclerosis. Neurology 40: 1764-1769.

Koopmans

. (1993) Magnetic resonance spectroscopy of multiple sclerosis: in vivo detection of myelin breakdown products (letter). Lancet 341: 631-632.

Davie

. (1994) Detection of myelin breakdown products by proton magnetic resonance spectroscopy. Brain 117: 49-58.

Paty

, Koopmans

, Willoughby

, Li

DKB

. (1988) Serial MRI studies in multiple sclerosis: a new method for assessing disease activity in both chronic progressive and relapsing patients. Neurology (suppl. 1): 255.

Miller

. (1988) Serial gadolinium enhanced magnetic resonance imaging in multiple sclerosis. Brain 111: 927-939.

10.

Rao

. (1989) Correlation of magnetic resonance imaging with neuropsychological testing in multiple sclerosis. Neurology 32: 161-166.

11.

Barkhof

, Hommes

, Scheltens

, Valk

. (1991) Quantitative MRI changes in gadolinium-DTPA enhancement after high-dose intravenous methylprednisolone in multiple sclerosis. Neurology 41: 1219-22.

12.

van Walderveen

MAA

. (1994) T₁ SE more specific than T₂ SE in identifying disabling lesions in multiple sclerosis. A quantitative follow-up study. In: Neurology (in press).

13.

Paty

. (1992) Does the MRI activity rate predict the clinical course of MS? Neurology 42 (suppl. 3): 427.

14.

Filippi

. (1994) Quantitative brain MRI lesion load predicts the course of clinically isolated syndromes suggestive of multiple sclerosis. Neurology 44: 635-641.

15.

Morrisey

(1993) The significance of brain magnetic resonance imaging abnormalities at presentation with clinically isolated syndromes suggestive of multiple sclerosis. A 5-year follow-up study. Brain 116: 135-146.

16.

Beck

. (1993) The effect of corticosteroids for acute optic neuritis on the subsequent development of multiple sclerosis. N Engl J Med 329: 1764-1769.

17.

Paty

, Li

DKB

. (1993) Interferon beta-lb is effective in relapsing-remitting multiple sclerosis. II. MRI analysis results of a multicenter, randomized, double-blind, placebo-controlled trial. UBC MS/MRI Study Group and the IFNB Multiple Sclerosis Study Group. Neurology 43: 662-667.